Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

Abstract

In hospitalized patients with Covid-19 pneumonia who were not receiving mechanical ventilation, tocilizumab reduced the likelihood of progression to the composite outcome of mechanical ventilation or death, but it did not improve survival. No new safety signals were identified. (Funded by Genentech; EMPACTA ClinicalTrials.gov number, NCT04372186.).

Keywords

TocilizumabMedicineMechanical ventilationInternal medicineHazard ratioPneumoniaConfidence intervalPlaceboPopulationOdds ratioDisease

Affiliated Institutions

Related Publications

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

John H. Stone , Matthew J. Frigault , Naomi Serling‐Boyd +45 more

Tocilizumab was not effective for preventing intubation or death in moderately ill hospitalized patients with Covid-19. Some benefit or harm cannot be ruled out, however, becaus...

2020 New England Journal of Medicine 1404 citations

Dexamethasone in Hospitalized Patients with Covid-19

In patients hospitalized with Covid-19, the use of dexamethasone resulted in lower 28-day mortality among those who were receiving either invasive mechanical ventilation or oxyg...

2020 New England Journal of Medicine 9762 citations

Dexamethasone in Hospitalized Patients with Covid-19.

Peter Horby , Wei Shen Lim , Jonathan Emberson +23 more

BACKGROUND: Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce progres...

2020 DiRROS repository (University of Mari... 8025 citations

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani , Ali Abbas , Fatima Abbas +97 more

In this study, we aimed to evaluate the effects of tocilizumab in adult patients admitted to hospital with COVID-19 with both hypoxia and systemic inflammation. This randomised,...

2021 The Lancet 1777 citations

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

Jason D. Goldman , David Chien Lye , David S.C. Hui +23 more

In patients with severe Covid-19 not requiring mechanical ventilation, our trial did not show a significant difference between a 5-day course and a 10-day course of remdesivir. ...

2020 New England Journal of Medicine 1419 citations

Publication Info

Year: 2020
Type: article
Volume: 384
Issue: 1
Pages: 20-30
Citations: 1297
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1297

OpenAlex

Cite This

APA Style

                            
                                
                                    Carlos Salama, 
                                
                                    Jian Han, 
                                
                                    Linda Yau
                                
                                et al.
                            
                            (2020). 
                            Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. 
                            New England Journal of Medicine
                            , 384
                            (1)
                            , 20-30.
                            https://doi.org/10.1056/nejmoa2030340
                        

Identifiers

DOI: 10.1056/nejmoa2030340